Jak-Stat Cytokine Receptors NewsLatest News On Jak-Stat Cytokine Receptors Anzupgo Approved in Europe for Severe Hand Eczema7/26/2024 9:47 AM Taper, Dose Down, Discontinue: The Struggle to Use Less Glucocorticoids7/25/2024 8:34 AM Difficult-to-Treat Rheumatoid Arthritis Resolved in 45% Through Additional Treatment Changes7/4/2024 2:24 AM Baricitinib Outperforms TNF Inhibitors in Rheumatoid Arthritis, but Safety Concerns Remain6/27/2024 7:40 AM Psoriatic Arthritis Drugs Comparably Improve Outcomes Across the Board6/19/2024 4:40 AM New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial6/19/2024 3:37 AM Upadacitinib Improves Giant Cell Arteritis in Phase 3 Trial6/14/2024 4:48 AM Real-World RA Data Find JAK Inhibitor Infection Risk Is Low and No Greater Than Other DMARDs, Other Than Herpes Zoster6/14/2024 3:45 AM FDA Extends Upadacitinib Indications to Children With Arthritis6/4/2024 3:51 PM In RA Treatment, Don't Overlook Underlying CV Risks5/16/2024 2:20 AM Most Patients With Rheumatoid Arthritis Meet European Medicines Agency's Janus Kinase Inhibitor Warning Criteria5/3/2024 3:57 AM
